| Term 
 | Definition 
 
        | 
ACE inhibitorPrevents angiotensin II activationDecr. ADH, BV, BP |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
AGII receptor antagnistBlocks pro-hypertensive effects of AgIIBinds AT1 receptorDecreased water retention, Na retention |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Alpha adrenergic antagonistCompetitive; A1 selectiveCan increase CO, usually temporary.  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
CaCh antagonist/blockerdecrease channel activitydecrease TPRCan increase CO; usually temporary |  | 
        |  | 
        
        | Term 
 
        | Nitroglycerin (Glyceryl Trinitrate) |  | Definition 
 
        | 
Exogenous NO donorNot explosive when in drug formMultiple routes of administrationVenous dilation, decr preloadUses: acute cardiogenic pulm edema, CHFTolerance does develop   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Exogenous NO donorarterial and venous dilationDecr preload, decr afterload, decr BPUses: hypertensive emergencies, acute CHFIV administrationLight sensitive; breaks down into cyanideFresh sol'n = slightly brownish, should be discarded if it is dark brown, orange or blue |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
PDE 5 InhibitorIncreased cGMP = Incr PKG = decr Ca, decr contraction: vasodilationMostly in lungs, corpus cavernosumManage pulmonary hypertension |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Potassium channel activatorHyperpolarization = decr CaCh opening, decr Ca entry/contractionDecr BP, TPR; rarely used |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Profound arterial dilationDecr IP3 induced calcium releaseRarely used for hypertensive crises; reflex tachycardia (baroreceptors), fluid retention (use with diuretic)Used with mitral insufficiency (decr afterload, decr mitral regurg) |  | 
        |  |